Publisher's Synopsis
Several large epidemiological studies on the comparative incidence and risk of side-effects with the various analgesics have shown the remarkable safety of dipyrone (metamizol), in clinical use since the early part of the century. New data is presented in five contributions to a satellite symposium of the World Conference on Clinical Pharmacology a
